In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
À_SOMBRA mycelium burial urn embraces ecological regeneration
In Brazil, the À_SOMBRA project has added a new eco-friendly end-of-life option. Designed by João Pedro Alves Cavalcanti and Jeanine Torres Geammal from the...
Shadow puppet art exhibit swaps animal leather for kombucha byproduct
In India, kombucha byproduct is being used to produce sustainable leather for shadow puppet exhibit Luminous Lore.
The exhibit aims to showcase Tholu Bommalata,...
Save the sturgeon with Umami Bioworks cultivated caviar
In Singapore, Umami Bioworks has unveiled cultivated caviar made from a mix of cultured sturgeon cells and plant-based ingredients.
The caviar alternative addresses many...